These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 22580362)
21. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates. Jansson LM; Dipietro JA; Elko A; Velez M J Matern Fetal Neonatal Med; 2007 Sep; 20(9):677-85. PubMed ID: 17701668 [TBL] [Abstract][Full Text] [Related]
22. The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome. Wachman EM; Newby PK; Vreeland J; Byun J; Bonzagni A; Bauchner H; Philipp BL J Addict Med; 2011 Dec; 5(4):293-9. PubMed ID: 21857233 [TBL] [Abstract][Full Text] [Related]
23. Buprenorphine: a new player in neonatal withdrawal syndrome. Nanda S; Brant R; Regier M; Yossuck P W V Med J; 2015; 111(1):16-21. PubMed ID: 25665273 [TBL] [Abstract][Full Text] [Related]
24. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study. McQueen KA; Murphy-Oikonen J; Desaulniers L Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717 [TBL] [Abstract][Full Text] [Related]
25. Infants of opioid-dependent mothers: neurodevelopment at six months. McGlone L; Mactier H Early Hum Dev; 2015 Jan; 91(1):19-21. PubMed ID: 25460252 [TBL] [Abstract][Full Text] [Related]
26. Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry. Grecco GG; Mork BE; Huang JY; Metzger CE; Haggerty DL; Reeves KC; Gao Y; Hoffman H; Katner SN; Masters AR; Morris CW; Newell EA; Engleman EA; Baucum AJ; Kim J; Yamamoto BK; Allen MR; Wu YC; Lu HC; Sheets PL; Atwood BK Elife; 2021 Mar; 10():. PubMed ID: 33724184 [TBL] [Abstract][Full Text] [Related]
27. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates. Leeman LM; Brown SA; Albright B; Skipper B; Hsi A; Rayburn WF J Matern Fetal Neonatal Med; 2011 Jul; 24(7):955-9. PubMed ID: 21142769 [TBL] [Abstract][Full Text] [Related]
28. Prenatal methadone exposure and child developmental outcomes in 2-year-old children. Levine TA; Davie-Gray A; Kim HM; Lee SJ; Woodward LJ Dev Med Child Neurol; 2021 Sep; 63(9):1114-1122. PubMed ID: 33462809 [TBL] [Abstract][Full Text] [Related]
29. The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment. Kreitinger C; Gutierrez H; Hamidovic A; Schmitt C; Sarangarm P; Rayburn WF; Leeman L; Bakhireva LN J Matern Fetal Neonatal Med; 2016 Mar; 29(5):783-8. PubMed ID: 25758627 [TBL] [Abstract][Full Text] [Related]
30. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study. Serra AE; Lemon LS; Mokhtari NB; Parks WT; Catov JM; Venkataramanan R; Caritis SN Am J Obstet Gynecol; 2017 Apr; 216(4):418.e1-418.e5. PubMed ID: 28024988 [TBL] [Abstract][Full Text] [Related]
31. Opioid neonatal abstinence syndrome: controversies and implications for practice. Wolff K; Perez-Montejano R Curr Drug Abuse Rev; 2014; 7(1):44-58. PubMed ID: 25323126 [TBL] [Abstract][Full Text] [Related]
32. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy. Johnson S; Martin PR Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626 [TBL] [Abstract][Full Text] [Related]
33. The effect of methadone dose regimen on neonatal abstinence syndrome. McCarthy JJ; Leamon MH; Willits NH; Salo R J Addict Med; 2015; 9(2):105-10. PubMed ID: 25599433 [TBL] [Abstract][Full Text] [Related]
34. Impaired vision in children prenatally exposed to methadone: an observational cohort study. Hamilton R; Mulvihill A; Butler L; Chow A; Irving E; McCulloch DL; McNeil A; Michael K; Spowart KM; Waterson-Wilson J; Mactier H Eye (Lond); 2024 Jan; 38(1):118-126. PubMed ID: 37402864 [TBL] [Abstract][Full Text] [Related]
35. Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads. Schiff DM; Wachman EM; Philipp B; Joseph K; Shrestha H; Taveras EM; Parker MGK Breastfeed Med; 2018 May; 13(4):266-274. PubMed ID: 29630387 [TBL] [Abstract][Full Text] [Related]
36. [Postpartum risk factors in the development of children born to opiate-addicted mothers; comparison between mothers with and without methadone substitution]. Ziegler M; Poustka F; von Loewenich V; Englert E Nervenarzt; 2000 Sep; 71(9):730-6. PubMed ID: 11042868 [TBL] [Abstract][Full Text] [Related]
37. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Burns L; Mattick RP Drug Alcohol Rev; 2007 Sep; 26(5):487-92. PubMed ID: 17701511 [TBL] [Abstract][Full Text] [Related]
38. [Breast feeding during methadon- and buprenorphin therapy]. Müller MJ; Lange M; Paul T; Seeliger S Klin Padiatr; 2011 Dec; 223(7):408-13. PubMed ID: 21969026 [TBL] [Abstract][Full Text] [Related]
39. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome. Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042 [TBL] [Abstract][Full Text] [Related]
40. Prevalence of Prenatal Opioid Exposure in Ontario, Canada, 2014-2019. Camden A; Ray JG; To T; Gomes T; Bai L; Guttmann A JAMA Netw Open; 2021 Feb; 4(2):e2037388. PubMed ID: 33595660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]